Hologic (HOLX) Short Interest Ratio & Short Volume $61.18 +0.32 (+0.52%) As of 10:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Hologic Short Interest DataHologic (HOLX) has a short interest of 5.87 million shares, representing 2.64% of the float (the number of shares available for trading by the public). This marks a 32.21% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 2.48 million shares to cover all short positions.Current Short Interest5,870,000 sharesPrevious Short Interest4,440,000 sharesChange Vs. Previous Month+32.21%Dollar Volume Sold Short$356.37 millionShort Interest Ratio2.3 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares224,390,000 sharesFloat Size222,470,000 sharesShort Percent of Float2.64%Today's Trading Volume895,332 sharesAverage Trading Volume2,484,572 sharesToday's Volume Vs. Average36% Short Selling Hologic? Sign up to receive the latest short interest report for Hologic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOLX Short Interest Over TimeHOLX Days to Cover Over TimeHOLX Percentage of Float Shorted Over Time Remove Ads Hologic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20255,870,000 shares $356.37 million +32.2%2.6%2.3 $60.71 2/28/20254,440,000 shares $281.42 million -25.0%2.0%1.8 $63.38 2/15/20255,920,000 shares $374.38 million -0.2%2.7%2.5 $63.24 1/31/20255,930,000 shares $427.79 million +5.9%2.7%2.6 $72.14 1/15/20255,600,000 shares $385 million +1.6%2.5%2.6 $68.75 12/31/20245,510,000 shares $397.22 million +6.4%2.5%2.9 $72.09 12/15/20245,180,000 shares $381.51 million -15.8%2.3%2.8 $73.65 11/30/20246,150,000 shares $488.93 million +34.0%2.8%3.9 $79.50 11/15/20244,590,000 shares $360.77 million -5.4%2.0%3.1 $78.60 10/31/20244,850,000 shares $392.22 million -16.5%2.1%3.3 $80.87 Get the Latest News and Ratings for HOLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter. 10/15/20245,810,000 shares $474.44 million +5.1%2.5%3.9 $81.66 9/30/20245,530,000 shares $450.47 million +6.8%2.4%3.6 $81.46 9/15/20245,180,000 shares $420.36 million -7.7%2.3%3.4 $81.15 8/31/20245,610,000 shares $455.76 million +8.5%2.5%3.7 $81.24 8/15/20245,170,000 shares $416.44 million +10.2%2.3%3.3 $80.55 7/31/20244,690,000 shares $382.75 million +3.8%2.1%3.1 $81.61 7/15/20244,520,000 shares $349.58 million -4.4%2.0%3.2 $77.34 6/30/20244,730,000 shares $351.20 million +1.9%2.1%3.4 $74.25 6/15/20244,640,000 shares $333.11 million -8.7%2.0%3.3 $71.79 5/31/20245,080,000 shares $374.80 million +12.4%2.2%3.4 $73.78 5/15/20244,520,000 shares $338.37 million -1.3%2.0%2.9 $74.86 4/30/20244,580,000 shares $347.03 million +1.3%2.0%2.8 $75.77 4/15/20244,520,000 shares $350.48 million +1.8%2.0%2.5 $77.54 3/31/20244,440,000 shares $346.14 million -4.5%1.9%2.5 $77.96 3/15/20244,650,000 shares $352.98 million -15.0%2.0%2.6 $75.91 2/29/20245,470,000 shares $403.69 million +24.6%2.4%3 $73.80 2/15/20244,390,000 shares $323.98 million -2.2%1.9%2.4 $73.80 1/31/20244,490,000 shares $334.24 million -20.1%1.9%2.3 $74.44 1/15/20245,620,000 shares $408.86 million -12.5%2.4%3 $72.75 12/31/20236,420,000 shares $458.71 million -16.2%2.7%3.4 $71.45 12/15/20237,660,000 shares $543.71 million -17.0%3.2%4.1 $70.98 11/30/20239,230,000 shares $658.10 million +49.4%3.9%5 $71.30 11/15/20236,180,000 shares $445.02 million -13.5%2.6%3.5 $72.01 10/31/20237,140,000 shares $472.45 million +3.8%3.0%4.1 $66.17 10/15/20236,880,000 shares $474.58 million +18.8%2.8%3.9 $68.98 9/30/20235,790,000 shares $401.83 million +6.0%2.4%3.2 $69.40 9/15/20235,460,000 shares $392.08 million +17.2%2.3%3.2 $71.81 8/31/20234,660,000 shares $348.29 million +6.2%1.9%2.6 $74.74 8/15/20234,390,000 shares $328.46 million -17.6%1.8%2.5 $74.82 7/31/20235,330,000 shares $423.31 million -2.6%2.2%3.3 $79.42This almost killed Elon Musk (chilling details emerge) (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 7/15/20235,470,000 shares $439.35 million +8.8%2.3%3.6 $80.32 6/30/20235,030,000 shares $407.28 million -13.1%2.1%3.5 $80.97 6/15/20235,790,000 shares $469.22 million +0.7%2.4%4.2 $81.04 5/31/20235,750,000 shares $453.62 million +6.1%2.4%4.3 $78.89 5/15/20235,420,000 shares $446.45 million No Change2.2%4.1 $82.37 10/31/20228,340,000 shares $565.45 million +4.4%3.4%5 $67.80 10/15/20227,990,000 shares $499.77 million -3.4%3.2%5 $62.55 9/30/20228,270,000 shares $533.58 million +9.1%3.4%5.2 $64.52 9/15/20227,580,000 shares $512.86 million -3.3%3.1%5 $67.66 8/31/20227,840,000 shares $529.67 million +9.5%3.2%5.1 $67.56 8/15/20227,160,000 shares $526.05 million -11.5%2.9%4.1 $73.47 7/31/20228,090,000 shares $577.46 million +9.5%3.3%4.4 $71.38 7/15/20227,390,000 shares $521.66 million -8.4%3.0%3.8 $70.59 6/30/20228,070,000 shares $559.25 million +1.6%3.3%4 $69.30 6/15/20227,940,000 shares $542.46 million -2.6%3.2%3.9 $68.32 5/31/20228,150,000 shares $613.45 million +18.3%3.3%4.2 $75.27 5/15/20226,890,000 shares $525.57 million +59.5%2.8%3.7 $76.28 4/30/20224,320,000 shares $311.00 million +2.4%1.8%2.5 $71.99 4/15/20224,220,000 shares $322.11 million +16.9%1.7%2.4 $76.33 3/31/20223,610,000 shares $277.32 million -2.7%N/A2.2 $76.82 3/15/20223,710,000 shares $263.26 million +16.3%1.5%2.2 $70.96 2/28/20223,190,000 shares $227.03 million +6.3%1.3%1.9 $71.17 2/15/20223,000,000 shares $211.86 million -2.0%1.2%1.8 $70.62 1/31/20223,060,000 shares $214.93 million -15.5%1.2%1.8 $70.24 1/15/20223,620,000 shares $251.92 million +13.8%N/A2.3 $69.59 12/31/20213,180,000 shares $243.46 million -7.8%1.3%2.1 $76.56 12/15/20213,450,000 shares $266.44 million -17.9%1.4%2.3 $77.23 11/30/20214,200,000 shares $313.87 million +1.5%1.7%2.8 $74.73 11/15/20214,140,000 shares $303.26 million +11.3%1.7%2.8 $73.25 10/29/20213,720,000 shares $272.71 million +0.8%1.5%2.6 $73.31 10/15/20213,690,000 shares $257.08 million -6.1%1.5%2.5 $69.67 9/30/20213,930,000 shares $290.07 million -20.9%1.6%2.4 $73.81 9/15/20214,970,000 shares $385.77 million +13.7%2.0%2.7 $77.62 8/31/20214,370,000 shares $345.89 million -8.2%1.7%2.3 $79.15 8/13/20214,760,000 shares $366.14 million -3.8%1.9%2.2 $76.92 7/30/20214,950,000 shares $371.45 million -19.5%2.0%2.1 $75.04 7/15/20216,150,000 shares $420.48 million -4.8%2.4%2.4 $68.37 6/30/20216,460,000 shares $431.01 million +9.1%2.6%2.5 $66.72 6/15/20215,920,000 shares $369.76 million -0.7%2.3%2.5 $62.46 5/28/20215,960,000 shares $375.84 million +8.4%2.4%2.6 $63.06 5/14/20215,500,000 shares $345.40 million -9.8%2.2%2.4 $62.80 4/30/20216,100,000 shares $404.00 million +22.5%2.4%2.8 $66.23 4/15/20214,980,000 shares $373.55 million +6.0%N/A0 $75.01 3/31/20214,700,000 shares $347.19 million -6.2%1.9%2.4 $73.87 3/15/20215,010,000 shares $354.61 million +4.6%2.0%2.5 $70.78 2/26/20214,790,000 shares $346.60 million +21.3%1.9%2.4 $72.36 2/12/20213,950,000 shares $316.08 million -7.5%1.6%2 $80.02 1/29/20214,270,000 shares $323.58 million +17.0%1.7%2.1 $75.78 1/15/20213,650,000 shares $279.15 million -5.0%1.4%1.9 $76.48 12/31/20203,840,000 shares $275.52 million -19.2%1.5%2 $71.75This almost killed Elon Musk (chilling details emerge) (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 12/15/20204,750,000 shares $352.31 million +8.7%1.9%2.5 $74.17 11/30/20204,370,000 shares $303.76 million -16.3%1.7%2.2 $69.51 11/15/20205,220,000 shares $364.04 million +16.5%2.1%2.4 $69.74 10/30/20204,480,000 shares $315.84 million +29.5%1.8%2.1 $70.50 10/15/20203,460,000 shares $230.09 million -7.2%1.4%1.6 $66.50 9/30/20203,730,000 shares $247.93 million +3.6%N/A1.7 $66.47 9/15/20203,600,000 shares $219.20 million +22.5%1.4%1.5 $60.89 8/31/20202,940,000 shares $175.58 million -1.3%1.2%1.2 $59.72 8/14/20202,980,000 shares $199.09 million -0.3%1.2%1.3 $66.81 7/31/20202,990,000 shares $208.64 million -29.0%1.2%1.2 $69.78 7/15/20204,210,000 shares $250.20 million -10.2%1.6%1.6 $59.43 6/30/20204,690,000 shares $267.33 million +13.6%1.8%1.7 $57.00 6/15/20204,130,000 shares $216.41 million +20.1%1.6%1.4 $52.40 5/29/20203,440,000 shares $182.32 million -6.3%1.3%1.1 $53.00 5/15/20203,670,000 shares $190.58 million -10.7%1.4%1.1 $51.93 4/30/20204,110,000 shares $205.91 million -6.0%1.6%1.3 $50.10 4/15/20204,370,000 shares $180.61 million +70.0%1.7%1.5 $41.33 HOLX Short Interest - Frequently Asked Questions What is Hologic's current short interest? Short interest is the volume of Hologic shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 5,870,000 shares of HOLX short. 2.64% of Hologic's shares are currently sold short. Learn More on Hologic's current short interest. What is a good short interest ratio for Hologic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOLX shares currently have a short interest ratio of 2.0. Learn More on Hologic's short interest ratio. Which institutional investors are shorting Hologic? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hologic: Wolverine Trading LLC, Group One Trading LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Hologic? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.64% of Hologic's floating shares are currently sold short. Is Hologic's short interest increasing or decreasing? Hologic saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 5,870,000 shares, an increase of 32.2% from the previous total of 4,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hologic's float size? Hologic currently has issued a total of 224,390,000 shares. Some of Hologic's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hologic currently has a public float of 222,470,000 shares. How does Hologic's short interest compare to its competitors? 2.64% of Hologic's shares are currently sold short. Here is how the short interest of companies compare to Hologic: Edwards Lifesciences Co. (1.64%), IDEXX Laboratories, Inc. (3.75%), ResMed Inc. (5.99%), DexCom, Inc. (2.94%), STERIS plc (1.17%), Insulet Co. (4.13%), Baxter International Inc. (3.60%), Globus Medical, Inc. (2.18%), Masimo Co. (6.75%), Teleflex Incorporated (5.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Hologic stock? Short selling HOLX is an investing strategy that aims to generate trading profit from Hologic as its price is falling. HOLX shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hologic? A short squeeze for Hologic occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOLX, which in turn drives the price of the stock up even further. How often is Hologic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOLX, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies EW Short Interest Data IDXX Short Interest Data RMD Short Interest Data DXCM Short Interest Data STE Short Interest Data PODD Short Interest Data BAX Short Interest Data GMED Short Interest Data MASI Short Interest Data TFX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOLX) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThinking of buying Nvidia? Read this firstI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.